News
Media
All VideosMedical World NewsPodcastsWeekly RecapCure ConnectionsInsightsSpecial ReportNeurologyLive Peer ExchangeMedcastPeers & PerspectivesRoundtable Discussions
Conferences
Conference CoverageConference Listing
CME/CE
More
Partners
Publications
NeurologyLiveBridging the GapsInternational Journal of MS Care
Resources
Expert AuthorsFDA NewsFeaturesFellows' CornerFuture Leaders in NeurologyGiants of Multiple SclerosisInteractive ToolsJob BoardLive EventsNeurology ResourcesSponsoredVirtual Events

Subscribe

  • News
  • Media
  • Conferences
  • CME/CE
  • Partners
  • Publications
  • Resources
  • Subscribe
  • Dementia and Alzheimer Disease
  • Epilepsy
  • Genetic Disorders
  • Headache and Migraine
    • Migraine
  • MS and Demyelinating Disorders
    • NMOSD
    • Multiple Sclerosis
    • MS Advanced Practice Providers
  • Movement Disorders
    • Parkinson Disease
  • Neuromuscular
    • Chronic Inflammatory Demyelinating Polyneuropathy
    • Muscular Dystrophy
    • Ataxia
  • Rare Diseases
  • Sleep Disorders
    • Narcolepsy
    • Insomnia
  • Stroke
Spotlight -
Expert Authors|
FDA News|
ECTRIMS 2025|
MDS 2025
Advertisement

Andrew C. Charles, MD

Advertisement

Articles by Andrew C. Charles, MD

Goals of Preventative Therapy for Migraine

ByJessica Ailani, MD,Andrew C. Charles, MD,Stephanie J. Nahas, MD,Christopher Gottschalk, MD,Rebecca Erwin Wells, MD, MPH
November 19th 2021

Expert neurologists share their goals and patient considerations for preventive migraine therapy.

Migraine: A Historic Perspective on Preventative Therapy

ByJessica Ailani, MD,Stephanie J. Nahas, MD,Christopher Gottschalk, MD,Andrew C. Charles, MD,Rebecca Erwin Wells, MD, MPH
November 19th 2021

Andrew C. Charles, MD, provides a historical perspective on the agents traditionally used for preventive migraine therapy.

  • Prev
  • 1
  • 2
  • Prev
Advertisement


Advertisement
Advertisement

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

1

How Multiple Sclerosis Affects Men

2

Understanding Ocrelizumab’s Impact on Advanced Progressive MS: Insights From Dr. Gavin Giovannoni

3

This Week on NeurologyLive® — October 13, 2025

4

Trofinetide Leads to Real-World Improvements in Rett Syndrome Symptoms, LOTUS Study Finds

5

Reflecting on Contributions to Child Neurology at 2025 CNS Annual Meeting: Brenda Banwell, MD, FRCPC, FAAN

  • About Us
  • Advisory Board
  • Editorial
  • Contact Us
  • Advertise
  • Contact MJH LS
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
HCP Live
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us